Press Releases Press Releases Latest Press Releases 3 August, 2021VERACYTE COMPLETES ACQUISITION OF HALIODX Veracyte, Inc. (Nasdaq: VCYT) today announced the company has completed its acquisition of HalioDx to solidify its reach into global markets while expanding its scientific capabilities and diagnostics scope into 8 of the 10 top cancers as defined by U.S. incidence. “This important acquisition is the culminating piece in a series of strategic initiatives and… Read More 1 June, 2021HALIODX AND VERACYTE SET PROPOSED ACQUISITION TERMS HalioDx SAS, the immuno-oncology diagnostics company pioneering the immunological diagnosis of cancers, announced today that Veracyte (NASDAQ: VCYT) and the… Read More 11 May, 2021IMMUNOSCORE® IS NOW AVAILABLE IN RECTAL CANCER FOR EXPERT CLINICAL CENTERS THROUGH AN INNOVATION ACCESS PROGRAM Immunoscore® heads up to become the standard precision tool for the “Watch and Wait” strategy in locally advanced rectal cancer… Read More 10 December, 2020HALIODX PARTNERS WITH DASA, THE LARGEST DIAGNOSTICS PROVIDER IN LATIN AMERICA, TO MAKE IMMUNOSCORE® AVAILABLE IN BRAZIL HalioDx SAS, the immuno-oncology diagnostic company pioneering the immunological diagnosis of cancers, today announced that it has signed an exclusive distribution agreement with… Read More 3 December, 2020EXPANDING IMMUNOSCORE® CLINICAL UTILITY ON 3000+ STAGE III COLON CANCER PATIENTS HalioDx SAS, the immuno-oncology diagnostic company pioneering the immunological diagnosis of cancers, today announced that Immunoscore® is evaluated in a new study with two… Read More 20 October, 2020NEW DATA REINFORCE IMMUNOSCORE® CLINICAL UTILITY IN LOCALIZED COLON CANCER Changes in patterns of oncology care with the incorporation of immune response in a study of Stage II colon cancer presented at ASCO Quality Care Symposium, and… Read More 9 October, 2020PALTOWN DEVELOPMENT FOUNDATION AND HALIODX TEAM UP FOR COLORECTAL CANCER TESTING CENTER HalioDx SAS, the immuno-oncology diagnostic company, today announced the company will be participating in COLONTOWN University (CU), a new online learning center for over 5,300 Colorectal Cancer… Read More 1 October, 2020JÉRÔME GALON HAS BEEN AWARDED THE FRENCH THE LEGION OF HONOR, OR “LEGION D’HONNEUR”, RECEIVED TODAY FROM GILLES BLOCH, CHAIRMAN AND CHIEF EXECUTIVE OFFICER OF INSERM Read the entire Press Release (in French only) here Read More 18 September, 2020HALIODX CONTRIBUTION TO PRECISION MEDICINE AT ESMO 2020 HalioDx SAS, the immuno-oncology diagnostic company, today announced that, at the European Society of Medical OncologyVirtual Congress 2020, HalioDx partners will present 2… Read More 10 September, 2020IMMUNOSCORE® TO SELECT PATIENTS IN THE POCHI TRIAL, A PHASE II MULTICENTER TRIAL TESTING IMMUNOTHERAPY WITH CHEMOTHERAPY AND BEVACIZUMAB IN METASTATIC COLORECTAL CANCER HalioDx SAS, the immuno-oncology diagnostic company, today announced that it has entered into a Collaboration Agreement with the FFCD, the French Cooperative Group dedicated… Read More Load More Press Releases
